Estimation of Plasma IC50 of Donepezil for Cerebral Acetylcholinesterase Inhibition in Patients With Alzheimer Disease Using Positron Emission Tomography-Reference-Cited by-同舟云学术

Estimation of Plasma IC50 of Donepezil for Cerebral Acetylcholinesterase Inhibition in Patients With Alzheimer Disease Using Positron Emission Tomography

Published:2010-03 Issue:2 Volume:33 Page:74-78
ISSN:0362-5664
Container-title:Clinical Neuropharmacology
language:en
Short-container-title:

Author:

Ota Tsuneyoshi,Shinotoh Hitoshi,Fukushi Kiyoshi,Kikuchi Tatsuya,Sato Koichi,Tanaka Noriko,Shimada Hitoshi,Hirano Shigeki,Miyoshi Michie,Arai Heii,Suhara Tetsuya,Irie Toshiaki

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Neurology (clinical),Pharmacology

Reference37 articles.

1. The efficacy and safety of donepezil in patients with AD: results of a US multicentre, randomized, double-blind, placebo-controlled trial.;Rogers;Dementia,1996

2. Protective effect of donepezil against Abeta (1-40) neurotoxicity in rat septal neurons.;Kimura;Brain Res,2005

3. Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies.;Ballard;Neurology,2007

4. Cognitive evaluation of disease-modifying efficacy of donepezil in the APP 23 mouse model for Alzheimer's disease.;Van Dam;Psychopharmacology (Berl),2008

5. Design and evaluation of radioactive acetylcholine analogues for mapping brain acetylcholinesterase (AChE) in vivo.;Irie;Nucl Med Biol,1994

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering the Role of Peroxisome Proliferator-activated Receptor α and Phosphodiesterase Type 5 Targets in Alzheimer's Disease;CNS & Neurological Disorders - Drug Targets;2023-09-04

2. In silico exploration of promising heterocyclic molecules against both acetylcholinesterase and butyrylcholinesterase enzymes;Journal of Biomolecular Structure and Dynamics;2023-07-21

3. Identification of promising inhibitory heterocyclic compounds against acetylcholinesterase using QSAR, ADMET, biological activity, and molecular docking;Computational Biology and Chemistry;2023-06

4. Synthesis and evaluation of new 2-oxo-1,2-dihydroquinoline-3-carboxamides as potent inhibitors against acetylcholinesterase enzyme;Medicinal Chemistry Research;2022-07-04

5. The PET tracer [ ¹¹ C]MK-6884 quantifies M4 muscarinic receptor in rhesus monkeys and patients with Alzheimer’s disease;Science Translational Medicine;2022-01-12